These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30146185)

  • 21. Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.
    Tinaz S; Chow C; Kuo PH; Krupinski EA; Blumenfeld H; Louis ED; Zubal G
    Clin Nucl Med; 2018 Jan; 43(1):e1-e7. PubMed ID: 29112012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease.
    Murtomäki K; Mertsalmi T; Jaakkola E; Mäkinen E; Levo R; Nojonen T; Eklund M; Nuuttila S; Lindholm K; Pekkonen E; Joutsa J; Noponen T; Ihalainen T; Kaasinen V; Scheperjans F
    Mov Disord; 2022 Jun; 37(6):1284-1289. PubMed ID: 35274368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine Transporter Availability in Early Parkinson's Disease is Dependent on Sunlight Exposure.
    Booij J; Tellier SP; Seibyl J; Vriend C
    Mov Disord; 2023 Nov; 38(11):2131-2135. PubMed ID: 37670567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson's Disease.
    Zhou Y; Su Y; Xu W; Wang W; Yao S
    Curr Neurovasc Res; 2019; 16(3):241-249. PubMed ID: 31258082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships of drooling with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
    Clin Neurol Neurosurg; 2020 Aug; 195():105951. PubMed ID: 32492588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal assessment of autonomic dysfunction in early Parkinson's disease.
    Stanković I; Petrović I; Pekmezović T; Marković V; Stojković T; Dragašević-Mišković N; Svetel M; Kostić V
    Parkinsonism Relat Disord; 2019 Sep; 66():74-79. PubMed ID: 31320275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug-naïve patients with Parkinson disease.
    Quarracino C; Otero-Losada M; Capani F; Pérez-Lloret S
    Clin Auton Res; 2020 Jun; 30(3):265-271. PubMed ID: 31848771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study.
    Ikeda K; Yanagihashi M; Miura K; Ishikawa Y; Hirayama T; Takazawa T; Kano O; Kawabe K; Mizumura N; Iwasaki Y
    J Neurol Sci; 2018 Aug; 391():5-9. PubMed ID: 30103971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit.
    Yu Z; Li Y;
    Medicine (Baltimore); 2021 Feb; 100(7):e24837. PubMed ID: 33607852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere.
    Miyamoto T; Akaiwa Y; Numahata K; Yoshizawa K; Sairenchi T; Miyamoto M
    Parkinsonism Relat Disord; 2022 Feb; 95():107-112. PubMed ID: 35093712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of autonomic symptoms with presynaptic striatal dopamine depletion in drug-naive Parkinson's disease: An analysis of the PPMI data.
    Kim R; Jun JS
    Auton Neurosci; 2019 Jan; 216():59-62. PubMed ID: 30236547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomic failure in Parkinson's disease is associated with striatal dopamine deficiencies.
    van Deursen DN; van den Heuvel OA; Booij J; Berendse HW; Vriend C
    J Neurol; 2020 Jul; 267(7):1922-1930. PubMed ID: 32162062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. REM sleep behavior disorder in early Parkinson's disease predicts the rapid dopaminergic denervation.
    Kim YE; Kim YJ; Hwang HS; Ma HI
    Parkinsonism Relat Disord; 2020 Nov; 80():120-126. PubMed ID: 32987358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic Correlates of Orthostatic Hypotension in de novo Parkinson's Disease.
    Umehara T; Oka H; Nakahara A; Shiraishi T; Sato T; Matsuno H; Komatsu T; Omoto S; Murakami H; Iguchi Y
    J Parkinsons Dis; 2021; 11(2):665-673. PubMed ID: 33361609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.